NDC 51662-1326

2% LIDOCAINE HCI

2% Lidocaine Hci

2% LIDOCAINE HCI is a Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Lidocaine Hydrochloride.

• Product ID: 51662-1326_78d8fb0a-bfaf-6599-e053-2991aa0a2e03
• NDC: 51662-1326
• Product Type: Human Prescription Drug
• Proprietary Name: 2% LIDOCAINE HCI
• Generic Name: 2% Lidocaine Hci
• Dosage Form: Injection, Solution
• Route of Administration: INFILTRATION; PERINEURAL
• Marketing Start Date: 2018-10-22
• Marketing Category: ANDA / ANDA
• Application Number: ANDA088327
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: LIDOCAINE HYDROCHLORIDE
• Active Ingredient Strength: 20 mg/mL
• Pharm Classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51662-1326-1

50 mL in 1 VIAL, MULTI-DOSE (51662-1326-1)

• Marketing Start Date: 2018-10-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1326-1 [51662132601]

2% LIDOCAINE HCI INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA088327
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-10-22
• Inactivation Date: 2020-01-31
• Reactivation Date: 2020-02-07

Drug Details

Active Ingredients

Ingredient	Strength
LIDOCAINE HYDROCHLORIDE	20 mg/mL

OpenFDA Data

• SPL SET ID: 78d8fb0a-bfae-6599-e053-2991aa0a2e03
• Manufacturer:
  • HF Acquisition Co LLC, DBA HealthFirst
• UNII:
  • V13007Z41A
• RxNorm Concept Unique ID - RxCUI:
  • 1010671

Pharmacological Class

• Amide Local Anesthetic [EPC]
• Amides [CS]
• Antiarrhythmic [EPC]
• Local Anesthesia [PE]

NDC Crossover Matching brand name "2% LIDOCAINE HCI" or generic name "2% Lidocaine Hci"

NDC	Brand Name	Generic Name
51662-1231	2% LIDOCAINE HCI	2% LIDOCAINE HCI
51662-1326	2% LIDOCAINE HCI	2% LIDOCAINE HCI
51662-1467	2% LIDOCAINE HCI	2% LIDOCAINE HCI